Blood Pressure DEA Policy Safety 
Cannabis Law Report
JUNE 28, 2021
Drug Enforcement Agency (“DEA”). Given the alarming and noticeable increase in ayahuasca border seizures in 2020, the main intent of these initial requests was to see how many seizures happened that year and if the government had a specific policy regarding these seizures. Customs Border Patrol (“CBP”) and U.S. 562 [2011]).
Cannabis Law Report
NOVEMBER 2, 2021
Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? May affect blood pressure, heart rate, intraocular pressure. The second argument is based on a DEA interim final rule on the topic of synthetic THC. Table of Contents. Executive Summary. What We Discovered.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 23, 2019
During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health.
The Cannigma
MAY 15, 2023
Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. Some programs may supply a blood-pressure cuff to check for high blood pressure, a common side effect of ketamine.
The Cannigma
SEPTEMBER 12, 2021
The safety of using these products however, is still unknown. Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. Rather, it was based on a policy that was created in the 1950s, before THC or CBD were isolated and before the endocannabinoid system was discovered.
Expert insights. Personalized for you.
97 
Let's personalize your content